TPG, AlpInvest, Pantheon back IK’s insurance single-asset deal
The transaction comes off the back of at least three other insurance-focused continuation fund deals in Europe over the past half-year.
Declaration explores process as anchor LP David Rubenstein seeks liquidity
The deal would allow Rubenstein to sell partial stakes in several assets, which will support his investment in the Baltimore Orioles Major League Baseball franchise, sources said.
StepStone leads on $762m Australian secondary deal
The innovative transaction involves StepStone providing funding for MLC Private Equity's seed portfolio and additional capital for its new investments.
StepStone leads on $175m insurance-focused continuation fund
Hudson Structured Capital Management has moved five assets out of a multi-sector insurance-focused fund into a continuation vehicle.
ICG’s Strategic Equity steps up as buyer on CVC’s single asset
LPs will be given the option to roll or sell on CVC’s continuation fund process for Multiversity, which is understood to be €1.5bn-€2bn in size, Secondaries Investor learns.
Continuation fund investors eye payout in Leonard Green’s SRS Distribution exit
While Leonard Green’s transaction is giving cash-out LPs the benefit of both processes, the 'quick flip' issue remains controversial in continuation fund deals where assets are quickly exited.
Wellspring to close nearly $1bn multi-asset deal with Neuberger, Lexington
Continuation fund will hold Wellspring portfolio companies SupplyOne, Cadence and Pentec Health, and includes $125m of unfunded capital for growth.
Montana, Committed Advisors among buyers of latest Taiwanese portfolio sale
Shin Kong Life's portfolio sale comes just weeks after Cathay Life sold $1.2bn of fund stakes to HarbourVest, as impending regulatory changes prompt insurers to rethink their private markets exposure.
Kaiser Permanente shops ‘multi-billion dollar’ portfolio as pricing strengthens
The deal comes as LP secondaries sales keep steady and drive activity with strong pricing and sellers eager to capture liquidity from private equity portfolios.
Goldman Sachs, AlpInvest lead Cinven’s Barentz secondary
The continuation fund for global life science ingredients distributor Barentz is understood to be around €850m in size.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: